Drugs / DNS-7801
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03306329 | Sep → Dec 2017 | Parkinson disease | Dart NeuroScience, LLC | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DNS-7801 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03306329 ↗ |
| Route | Oral | “DNS-7801 (low-dose) tablets administered once daily.” NCT03306329 ↗ |